On Tuesday, iBio Inc (NASDAQ: IBIO) was 10.00% up from the session before settling in for the closing price of $1.1. A 52-week range for IBIO has been $0.56 – $6.89.
Annual sales at Healthcare sector company grew by 64.37% over the past five years. When this article was written, the company’s average yearly earnings per share was at 84.76%. With a float of $21.87 million, this company’s outstanding shares have now reached $22.49 million.
iBio Inc (IBIO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward iBio Inc stocks. The insider ownership of iBio Inc is 2.74%, while institutional ownership is 25.62%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.
iBio Inc (IBIO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.48 earnings per share (EPS) during the time that was less than consensus figure (set at -0.46) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.80% during the next five years compared to 64.37% growth over the previous five years of trading.
iBio Inc (NASDAQ: IBIO) Trading Performance Indicators
You can see what iBio Inc (IBIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 54.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of iBio Inc (IBIO)
iBio Inc (NASDAQ: IBIO) saw its 5-day average volume 1.37 million, a negative change from its year-to-date volume of 2.01 million. As of the previous 9 days, the stock’s Stochastic %D was 15.89%.
During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 52.15%, which indicates a significant increase from 17.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1687 in the past 14 days, which was higher than the 0.0901 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0558, while its 200-day Moving Average is $1.6528. Nevertheless, the first resistance level for the watch stands at $1.2833 in the near term. At $1.3567, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4433. If the price goes on to break the first support level at $1.1233, it is likely to go to the next support level at $1.0367. The third support level lies at $0.9633 if the price breaches the second support level.
iBio Inc (NASDAQ: IBIO) Key Stats
There are 22,487K outstanding shares of the company, which has a market capitalization of 27.21 million. As of now, sales total 400 K while income totals -18,380 K. Its latest quarter income was 100 K while its last quarter net income were -5,720 K.
